R6HS-infected cells was at the same reduced level as that found in cells infected with the parental mutant D6/3/1. The same G-to-T transversion at nucleotide 1380 in the UL97 coding sequence is present in both R6HS and D6/3/1. This mutation results in the substitution of isoleucine for methionine at amino acid residue 460. In an alignment of the R6HS UL97 amino acid sequence with the amino acid sequences of a wide range of protein kinase family members, methionine 460 lies within a highly conserved region which may function in nucleotide binding and phosphate transfer.
Human cytomegalovirus (HCMV) belongs to the herpesvirus family. Viruses in this family characteristically establish latent infections, which can be reactivated. Although the majority of HCMV infections are asymptomatic, primary infection or secondary reactivation can result in serious disease in patients with AIDS and organ transplant recipients who are immunosuppressed (21, 25, 30) . Ganciclovir (GCV) was the first antiviral agent approved for treatment of HCMV disease; however, GCV-resistant strains have been isolated from both laboratory strains and clinical samples (3, 11, 20, 29, 33) .
GCV, like acyclovir (ACV), is a nucleoside analog. HCMV is sensitive to GCV but relatively resistant to ACV, although ACV has been used prophylactically to reduce the incidence of HCMV infection following organ transplantation (1, 22) . The ultimate viral target of these nucleoside analogs is the DNA polymerase; however, GCV and ACV require intracellular phosphorylation for activity. This means that resistance can be generated by mutations in two viral genes: the DNA polymerase gene and the gene encoding the kinase which monophosphorylates the drug (4, 9, 31) . In herpes simplex virus, the enzyme which phosphorylates both ACV and GCV is the thymidine kinase (27) ; however, HCMV does not encode a thymidine kinase (6) . Instead, recent evidence indicates that GCV is phosphorylated by a protein kinase homolog encoded by the HCMV UL97 open reading frame (19, 31) . Homologs of this gene have been found in almost all of the human herpesviruses (7, 10, 28) .
We previously isolated three independent GCV-resistant mutants of the GCV-sensitive HCMV strain AD169. These mutants have mutations in the DNA polymerase gene (20) AD169 -infected HFF; (C) D6/3/1-infected HFF; (D) R6HS-infected HFF. GCV and GCV-monophosphate standards were analyzed with each set of cell extract samples. The retention time for GCV was 10 min, and the retention time for GCV-monophosphate was 4.5 min. These retention times correspond to fractions 33 and 15, respectively. quence ambiguities and compressions were resolved by substitution of dideoxyinosine for dideoxyguanosine in the termination reactions followed by the addition of 1.0 ,ul of a solution containing 1.0 mM concentrations of each of the four nucleoside triphosphates (Pharmacia, Uppsala, Sweden), lx Sequenase buffer (United States Biochemical), and 5 U of terminal deoxytransferase (Promega, Madison, Wis.). The terminal deoxytransferase reaction mitures were incubated at 37°C for 30 min (12) , and then the reactions were stopped according to the Sequenase protocol.
Production of recombinant virus. Transfection of HFF monolayers was performed as previously described (20) . Briefly, monolayers were infected with the wild-type strain AD169 and then transfected with a linearized plasmid containing the mutant UL97 open reading frame on a HindIII restriction fragment insert. Recombinant virus was selected and plaque purified in the presence of 15 ,uM GCV.
RESULTS
Source of HCMV strains. The wild-type strain that we have used is AD169. D1/3/4, D6/3/1, and D10/3/2 are three GCVresistant double mutants of AD169. These three mutants are plaque-purified strains from 3 of 10 separate tube cultures of AD169, which were maintained and passed independently in increasing concentrations of GCV. We have already identified polymerase mutations in each of these strains (20); however, the reduced level of GCV phosphorylation in mutant-infected cells ( Fig. 1) indicated the presence of an additional kinase mutation. The derivation of the kinase recombinant R6HS will be discussed below.
For comparative analysis of wild-type UL97 kinases, we have used the GCV-sensitive clinical strain P8. GCV anabolism in P8-infected cells is similar to that of the wild-type strain AD169 (33) . The phenotype of P8, therefore, indicates that both the polymerase and kinase are wild type.
DNA sequencing of the UL97 kinase open reading frame. The HindIlI S restriction fragment containing the UL97 open reading frame from each of the three double mutants (D1/3/4, D6/3/1, and D10/3/2) was cloned in pUC18. Comparison of the DNA sequences of this open reading frame from the mutants and that of the wild-type strain AD169 showed that the same point mutation was present in all three mutants. There is a G-to-T transversion at position 1380 ( Fig. 2) which results in an amino acid substitution of isoleucine for methionine at amino acid residue 460 (Fig. 3) . The remaining sequence is The UL97 open reading frame of the clinical strain, P8, is present on a much larger Hindlll fragment. This fragment was also cloned in pUC18 and sequenced for comparison with the AD169 sequence. P8 retains methionine at residue 460 (Fig.  3) . Within the sequence shown in Fig. 2 , P8 has one silent base change from AD169 at position 1362. The entire P8 UL97 coding sequence has a total of 21 base changes from AD169, only 3 of which result in amino acid substitutions. These substitutions are aspartate for asparagine 68, valine for isoleucine 244, and glutamate for aspartate 605. All of these residues occur outside the central region, which has been proposed to have catalytic function (13) .
Transfer of the UL97 mutation from D6/3/1 to AD169. To correlate GCV resistance with the methionine-to-isoleucine substitution, the linearized plasmid containing the HindIII S fragment of D6/3/1 was transfected into cells infected with the wild-type strain AD169. R6HS is the GCV-resistant strain resulting from the transfer. Antiviral susceptibility profiles. Table 1 than that of the double mutants but fivefold higher than that of the GCV-sensitive strain AD169 (ED5O = 10 ,uM). R6HS is sensitive to HPMPA and HPMPC. Since these drugs do not require kinase activation (26) , this sensitivity indicates that the polymerase is wild type. In addition, R6HS is highly resistant to AraT, unlike the double mutants, which are hypersensitive to this drug. We previously observed that AraT resistance appears to be associated with the wild-type DNA polymerase, while AraT hypersensitivity is associated with the mutant polymerase (20) . R6HS is fourfold more resistant to ACV than both the wild-type and double-mutant strains.
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P8 R6HS HHV-6 (15R) EBV (BGLF4) VZV (47) HSV (UL1 3) Consensus Intracellular GCV anabolism. The level of intracellular GCV anabolism was previously determined to be lower in cells infected with the GCV-resistant double mutants than in cells infected with AD169 (20) . Figure 1 shows the reverse-phase HPLC profile for cells infected with R6HS. Unphosphorylated GCV is retained in fractions 31 to 34, while phosphorylated derivatives of GCV (mono-, di-, and triphosphates) are retained in fractions 8 to 18. The level of GCV phosphorylation in R6HS-infected cells (Fig. 1D ) is more than 10-fold lower than that of AD169-infected cells (Fig. 1B) . This level is similar to that of the parental mutant D6/3/1 (Fig. 1C) .
Correlation of UL97 mutation with conserved protein kinase domains. The UL97 open reading frame of R6HS was sequenced. The only base change was the G-to-T transversion at position 1380, which is identical to that of the parental mutant D6/3/1 (Fig. 2) . The amino acid substitution is, therefore, also isoleucine for methionine at residue 460. Figure 3 shows a portion of the amino acid sequence of the most highly conserved region in all of the human herpesvirus UL97 homologs (7). There are 10 residues which are conserved and 5 more which are partially identical with only conservative changes. Methionine 460 is next to an invariant asparagine residue. Although this methionine residue is not found in all of the homologs, it is conserved in human herpesvirus 6 (HHV-6). P8, the GCV-sensitive HCMV clinical strain, also retains methionine at this residue. Figure 4 shows an alignment of the amino acid sequence encompassing the methionine 460 residue with similar sequences from a wide range of protein kinases and bacterial phosphotransferases. There are three residues which are positionally invariant. The pattern is H-X-D-X-X-X-X-N, where the underlined X indicates the position of the methionine conserved in both HCMV and HHV-6.
DISCUSSION
The mutation that we have found in the UL97 gene occurs in three independently isolated GCV-resistant strains of 
Alignment of amino acid residues from the putative catalytic domain of human herpesvirus protein kinase homologs (from reference 7) . Individual viral open reading frame designations are in parentheses following the virus name. The initial amino acid residue number for each virus is listed before each sequence. The consensus sequence is given at the bottom. Asterisks indicate residues which vary only by conservative substitutions. The shaded residue shows the site of the R6HS mutation. The boxed region contains the most widely conserved residues, which are expanded in Fig. 4 . HCMV. There are two different DNA polymerase mutations found among these strains. The single UL97 mutation is significant in that it occurs within a region of the gene that contains conserved residues shared by a large number of cellular and viral protein kinases as well as a number of bacterial phosphotransferases (2, 5, 7, 10, 13, 15, 16, 34) . This corresponds to region VI defined by Hanks et al. (13) . Region VI is the most highly conserved among the kinases. There are three residues, histidine, aspartate, and asparagine, which are present at the same positions in all of the protein kinases listed in Fig. 4 . There is occasional variability at the histidine site in a few protein kinase sequences not shown; however, the aspartate and asparagine residues are invariant. The methionine residue which is changed to isoleucine in our mutants lies next to the invariant asparagine. This conserved region of protein kinases has been proposed to be part of a central catalytic domain which may be involved in nucleotide binding and phosphate transfer (5, 7, 13, 28) . Although the amino acid sequence indicates that the UL97 product may have protein kinase or phosphotransferase activity, Sullivan and coworkers (31) identified this open reading frame as the coding sequence for the GCV kinase. Others have demonstrated kinase activity associated with the UL97 protein product expressed in heterologous cell culture systems (14, 19 
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FIG. 4. Alignment of a highly conserved amino acid sequence motif found in a wide selection of protein kinase family members. Shaded amino acid residues are conserved. The methionine residue which is substituted with isoleucine in the R6HS sequence is boxed. Numbers at the right are references for the amino acid sequences. mutants do not show increased ACV resistance; however, we have observed that transfer of polymerase mutations from these strains can confer hypersensitivity to ACV (data not shown). Both mutations in the same virus may neutralize the effect of each individual mutation on ACV susceptibility.
The fact that a conservative substitution of isoleucine for methionine results in GCV resistance suggests that this amino acid residue is functionally important for the HCMV enzyme. Others have also reported four unrelated GCV-resistant clinical strains which have valine substituted at the same methionine residue. Marker transfer has confirmed that this substitution confers GCV resistance (2a, 32) . The only other herpesvirus homolog which has methionine at this position is found in HHV-6. This is significant, because HHV-6 appears to be the human herpesvirus most closely related to HCMV (17) . The GCV-sensitive clinical strain P8 predictably retains methionine at this site.
Since the normal substrate for the UL97 kinase is not known, studies of the functions of other virus homologs may suggest possible roles for the UL97 protein in the HCMV replication cycle. Evidence from several laboratories indicates that the protein product of the herpes simplex virus type 1 homolog, UL13, is a phosphorylated component of the virion, which not only may phosphorylate the regulatory protein ICP22 but also may be autophosphorylated (8, 23, 24) .
A number of other DNA viruses encode kinases which have amino acid sequence motifs similar to that in which we have found the UL97 mutation. PRV UL13 is the pseudorabies virus homolog (10), which appears to be autophosphorylated and to have serine/threonine kinase activity. The vaccinia virus BlR product is a serine/threonine kinase and is found in the virion (18) . African swine fever virus encodes a kinase which phosphorylates serine and also appears to be a virion protein (2) .
Analysis of these other kinases suggests potential properties for investigation of the UL97 protein, which include serine/ threonine phosphorylation activity, autophosphorylation, and presence in the mature virion. An understanding of the function of the UL97 protein is important, because the majority of reported GCV-resistant clinical isolates demonstrate reduced GCV anabolism (11, 29) . The mapping of specific mutations to the UL97 gene will provide further evidence for the role of the kinase in GCV anabolism. Identifying mutations responsible for drug resistance could be useful in the development of rapid methods to detect drug-resistant HCMV strains arising during treatment. In addition, these mutations will help to define the amino acid residues which are important for the normal enzymatic function of this viral product.
